Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF AUGUST 29, 2012 FBO #3931
SOLICITATION NOTICE

D -- TABLE TRANS SOFTWARE RENEWAL - TABLE TRANS SOFTWARE

Notice Date
8/27/2012
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
511210 — Software Publishers
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
 
ZIP Code
20857-0001
 
Solicitation Number
1110757-12-DH
 
Archive Date
9/15/2012
 
Point of Contact
Debbie Hammond, Phone: (301) 827-7157
 
E-Mail Address
deborah.hammond@fda.hhs.gov
(deborah.hammond@fda.hhs.gov)
 
Small Business Set-Aside
N/A
 
Description
RFQ FOR TABLE TRANS SOFTWARE The U.S. Food and Drug Administration intends to negotiate and award on a sole source basis to PPD Development, LP, under the authority 41 U.S.C. 253(c) (1), as set forth in FAR 6.302-1. This acquisition is to provide Table Trans software licenses and maintenance support currently being used for the FDA's Adverse Event Data from AERS. The Food and Drug Administration (FDA) requires TableTrans software which is a data mapping tool that can help with converting data to a more usable format. Modifying data to a usable format has been a major initiative at the FDA. Much of the data submitted to FDA requires reformatting to be used in analytic tools. TableTrans is used to prepare the Adverse Event Data from AERS for use in Empirical Signal, a data mining tool. This tool can also be used to modify pre-clinical and clinical trial data. The period of performance for the annual maintenance is one year. This requirement is currently being provided by PPD Development, LP and there are no resellers or 3rd parties that can provide these licenses. There are no other sources that can provide maintenance for this software. The purpose of this requirement is to provide additional licenses and software support for the FDA. The software must support data transformations as a sequence of basic steps. Specifically, the software should posses the following salient characteristics: • Specify, execute and automatically document complex data transformations • Specify and extract transformed data interactively or in batch mode to files or databases • Provides a wide range of built-in transformation operators and database functions to minimize programming • Visual Programming o Simplify data management and retrieval tasks through visual programming. o Transform data visually, step-by-step o Include visual transformations diagrams in order to facilitate explanation and modification • Selection from many data transformation operators • Provide SQL functionality without programming • Automatic documentation • 21 CFR compliant Additionally, the software vendor shall provide support, including installation support, updates and technical support during regular business hours. Technical support should be available through telephone, or email during regular business hours. The NAICS code is 511210 and the size standard is $25M. This notice is not a request for competitive quotations. However, any firm that believes it can meet these requirements may submit a written response via email to Debbie Hammond at the email address below by 10:00 AM Eastern Time on August 31, 2012. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. Information received will be considered; however, a determination by the Government not to compete the proposed acquisition based on responses to this notice is solely within the discretion of the Government. If no responses are received, the FDA will proceed with the sole source award to PPD Development, LP, 929 N Front St., Wilmington, NC 28401. The anticipated award date of this order is around August 31, 2012. No collect calls will be accepted. If you have any questions regarding this announcement, please contact dhammon1@oc.fda.gov.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1110757-12-DH/listing.html)
 
Place of Performance
Address: 10903 NEW HAMPSHIRE AVENUE, BLDG, 21, WHITE OAK CAMPUS, SILVER SPRING, Maryland, 20993, United States
Zip Code: 20993
 
Record
SN02857393-W 20120829/120828000946-dbacc0e36cc3e0480f8d1ae09e546af8 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.